Abiopharma

🔍 JABRE WISSAM G (Executive)

Company: NetApp, Inc. (NTAP)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 1,356 shares of Common Shares (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: false | shares_owned_after: 39,294.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 684 shares of Common Shares at $204.99 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: false | shares_owned_after: 38,610.00 | transaction_form_type: 4
• Sold 1,356 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: false | shares_owned_after: 14,916.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Reflects 134 shares purchased at $83.9545 per share under the NetApp Employee Stock Purchase Plan on May 29, 2026.
• F3: On July 1, 2025, the reporting person was granted 21,696 restricted stock units. Restricted stock unit awards shall vest as to twenty-five percent (25%) of the shares May 15, 2026 and 1/16th (6.25%) of the shares quarterly thereafter for the next three years, subject to continued service on each applicable vesting date.